UNSPSC 51191568: Theobromide or theobromine or xantheose

This classification denotes a bronchodilator with the molecular formula C7H8N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OBD445WZ5P, chemically known as 3,7-dimethylxanthine but generally known as theobromine, which bears US NIH Compound Identifier 5429. European Medicines Agency schedules Theobromine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15511MIG. World Health Organization schedules theobromine in its Anatomical Therapeutic Chemical (ATC) Classification.

SMILES: O=C1[NH]C(=O)N(C2NCN(C12)C)C. SMILES: O=C1[NH]C(=O)N(C2NCN(C12)C)C.

UNSPSC 51191568 Theobromide or theobromine or xantheose is a Commodity code that shows minimal alignment with recent state and local procurement activity. The two most recent opportunities posted under this code—a City of Meriden IFB for sodium bisulfite (a water-treatment chemical) due July 29, 2026, and a Minnesota Multistate Cooperative Purchasing Alliance RFP for generic pharmaceuticals and over-the-counter products due March 26, 2026—are unrelated to theobromine or xanthine derivatives, which are alkaloid compounds used in pharmaceutical formulations, food additives, and specialty chemicals. The sodium bisulfite solicitation targets municipal water pollution control, while the MMCAP pharmaceutical RFP targets multi-state health-system supply chains through wholesaler distribution networks. Neither opportunity reflects demand for the alkaloid compounds the code nominally covers.

State and local procurement activity under this code appears dormant or misclassified in available records. The City of Meriden and MMCAP are the only issuing bodies present in recent opportunities, and their actual scope of work diverges sharply from the code's stated commodity. No geographic concentration emerges because the opportunities themselves fall outside the theobromine-alkaloid product family. Business development professionals should verify whether state and local governments are actively sourcing theobromine, theobromide, or xantho derivatives under alternative code classifications, or whether end-use demand for these compounds through state and local channels remains marginal relative to pharmaceutical and chemical supply procurement.